Get ready for our #hotline session at #EuroPCR! 🌟 Join us from 14:45 - 16:15 in Theatre Havane (Level 3), where we'll share insights from our Late-Breaking Trials on mitral and tricuspid valve repair across diverse patient populations. PCRonline 🫀 Atsushi Sugiura Philipp Lurz

This year's #EuroPCR was the first without Professor Alain Cribier, whose pioneering spirit and dedication inspired countless researchers and interventional cardiologists. Your legacy lives on in our work and hearts. #InMemoriam PCRonline 🫀 Cardiovascular Research Foundation European Society of Cardiology Journals

Great Debate: Should SGLT2 inhibitors be first-line treatment in heart failure with reduced ejection fraction? #EHJ academic.oup.com/eurheartj/adva… #SGLT2i #HFrEF European Society of Cardiology European Society of Cardiology Journals

Case reports EHJCaseReports Editor-in-Chief - great opportunity for new collaborations Hannah Billig Grigorios Korosoglou #FlorianAndre #NorbertFrey Philipp Sommer Christian Sohns Dirk Westermann Holger Thiele Herzmedizin.de Holger Eggebrecht Young DGK Baravan Al-Kassou | MD AGIK doi.org/10.1093/ehjcr/…

Interesse an der interventionellen Kardiologie? 🫀〰️ Baravan Al-Kassou | MD Daniel Messiha, MD Dominik Hubricht Luis Eichelmann 🇪🇺 Henrike Hillmann Alles, was Ihr für den Einstieg braucht ⬇️⬇️⬇️⬇️⬇️

2024 #ESCGuidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of ESC European Society of Cardiology and endorsed by EACTS. #EHJ academic.oup.com/eurheartj/adva… #ESCCongress European Society of Cardiology European Society of Cardiology Journals #CCS #guidelines

The interactive session on the new #ESCGuidelines at #ESCCongress 2024 in London is absolutely fantastic. Direct discussions with the Task Force members provides valuable insights. European Society of Cardiology Journals ESC President

Outstanding session on systemic #inflammation in stable and unstable ischaemic heart disease at #ESCCongress, featuring an exceptional panel Dr Roxana Mehran It offered a fascinating new perspective on treating unstable ischaemic heart disease beyond interventional strategies.

The #Matterhorn Trial, presented at #ESCCongress, showed that in patients with #heartfailure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery for key outcomes at 1 year. A promising alternative! NEJM European Society of Cardiology Journals

Results from the #Tri.fr trial show that T-TEER plus optimal medical therapy led to a significant improvement in the primary endpoint, including death, cardiovascular hospitalization, functional class, and patient-reported outcomes. #ESCCongress

#RESHAPE-HF2, presented at #ESCCongress, showed that adding #TMVR to medical therapy in heart failure patients with moderate to severe functional mitral regurgitation significantly reduced hospitalizations and cardiovascular deaths, and improved health status. European Society of Cardiology NEJM

In the NOTION-3 trial of percutaneous coronary intervention or conservative treatment in patients undergoing TAVI, PCI was associated with a lower risk of a composite of death, MI, or urgent revascularization at a median of 2 years. Full results: nej.md/3AH5WJo #ESCardio

Join us today for 'The 50 Shades of TAVI'! 📅 01 Sep, 15:45-16:45 📍Science Box 3 - Research Gateway. Explore the latest in TAVI treatment during our Session. Don't miss it! #TAVI #Research #ESCCongress

'London' is packed with enthusiastic attendees for HOT LINE 8, despite it being Saturday evening and the sun shining outside. ☀️ Could it be the outstanding panel and/or the exciting studies drawing everyone in? #HOTLINE #ESCCongress European Society of Cardiology Dr Roxana Mehran Hany Ragy Mamas A. Mamas

#SENIOR-RITA Trial 💃 In older adults with #NSTEMI, invasive strategy showed no significant reduction in the composite primary outcome including cardiovascular #death or nonfatal #MI compared to conservative strategy over 4.1 years. #ESCCongress NEJM

#EARTH-STEMI meta-analysis 🌍 Complete revascularization in older #STEMI pat with multivessel disease reduced cardiovasc events vs. culprit-only revascularization at 4 years. Similar safety profile in both groups. More long-term data needed. #ESCCongress European Society of Cardiology Davide Capodanno

#EssenFeelsTheBeat Shibu Mathew über #Cannabis und #Afib 🔹Cannabiskonsum steigt in Europa 🔹Akut: Verdopplung der Herzfrequenz für bis zu 3h 🔹 Chronisch: AV-Blockierung möglich 🔹insgesamt erhöhte Inzidenz von atrialen Tachykardien Essen - feels the Beat Tienush Rassaf Shibu Mathew Uniklinikum Essen

The annual retreat of the TRR259 has officially started! Over the next 2 days, experts from Rheinische Friedrich-Wilhelms-Universität Bonn, Universität zu Köln, and Heinrich-Heine-Universität Düsseldorf will come together to deepen our understanding of aortic disease mechanisms. Exciting discussions and collaborations ahead! DFG public | @[email protected] GrandochLab